Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 200.79

-0.2%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Machaon who wrote (20548)	5/11/1998 11:16:00 PM
From: Andrew H	Read Replies (3) of 32384

>>I think that going from 9 to 84 cents for 1999 earnings would be a good guess for the Seragen effect >> IMO, it is highly unlikely that the SRGN drug for CTCL is going to bring LGND anywhere near .84/share for 1999, even in combination with Panretin which should be a much better seller. If 37% of patients had to quit from the side effects, a significant part of the target population will be eliminated from treatment. Of course these patients may not be fully representative of the target populations. Its going to take some time for the drug to penetrate the market, assuimg it is approved.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next